Hyperbaric Chamber for Immune Support: What HBOT Does and Doesn’t Do

HBOT modulates immune function in several documented ways. Here’s an honest look at what this means for immune health.
hyperbaric chamber for immune support

Hyperbaric oxygen therapy does not “boost” immunity in healthy people, and no clinical trial shows it prevents everyday infections. Its documented immune role is narrower and more specific: it powers the oxygen-dependent killing that neutrophils use against severe infection (gas gangrene is one of the 14 FDA-cleared HBOT indications), and it measurably mobilizes stem cells, with circulating CD34+ cells roughly doubling after a single session and rising about eightfold over 20 sessions.

Evidence Strength: HBOT and Immune Function
Severe infection (gas gangrene, osteomyelitis)

Strong
Anti-inflammatory effect in chronic disease

Moderate
Stem cell mobilization

Moderate
General “immune boost” in healthy people

Limited

HBOT’s ability to raise tissue oxygen levels has real, documented effects on immune function, but those effects are targeted rather than a generic lift. It is one of several chronic conditions being studied with HBOT where the mechanism matters more than the marketing.

Does HBOT Boost Your Immune System?

Not in the way wellness marketing implies. The phrase “immune support” usually suggests that more immune activity is better. In reality, the immune system needs precise regulation. Too little activity and infections go unchecked; too much and inflammation causes tissue damage and autoimmune disease. HBOT modulates immune function in both directions depending on context. It enhances innate killing capacity while suppressing excessive inflammatory signaling. Calling that a “boost” misses what actually happens.

What HBOT Does to Immune Function

Immune effect What it does Evidence context
Oxidative pathogen killing Fuels the oxygen-dependent oxidative burst neutrophils and macrophages use to destroy bacteria Established in severe anaerobic infection
Cytokine suppression Lowers pro-inflammatory signaling (TNF-alpha, IL-1, IL-6) via reduced NF-kB activity Chronic inflammatory and rheumatic disease (moderate)
Stem cell mobilization Raises circulating CD34+ cells ~2x after one session, ~8x over 20 Wound healing and tissue repair (Thom 2006)
General “immune boost” No documented benefit Healthy people (no trial evidence)

Enhanced Killing of Pathogens

Neutrophils and macrophages, the front-line cells that engulf and destroy bacteria, use reactive oxygen species (hydrogen peroxide, superoxide, hydroxyl radical) as their primary weapons. This oxidative burst is oxygen-dependent. In tissues with compromised blood flow, where oxygen tension is low, these cells cannot kill bacteria effectively. HBOT restores and amplifies their killing capacity. This mechanism is the basis for HBOT’s established role in treating severe infections, particularly gas gangrene and refractory osteomyelitis, both recognized by the Undersea and Hyperbaric Medical Society as approved indications.1 The infections and HBOT article covers the clinical applications in detail.

Anti-Inflammatory Effects

While HBOT enhances innate immune killing, it simultaneously reduces systemic inflammation. A 2025 review in Frontiers in Medicine examining HBOT in rheumatic and immune diseases described how repeated sessions suppress NF-kB, a master transcription factor that drives production of pro-inflammatory cytokines including TNF-alpha, IL-1, IL-6, and IL-8.2 A 2026 narrative review in Frontiers in Immunology reached a similar conclusion, describing how HBOT reshapes immune metabolism and rebalances regulatory T cells against pro-inflammatory Th17 cells across autoimmune disease, chronic inflammation, and cancer.3

This dual action, enhanced killing plus reduced inflammation, makes HBOT’s immune effects context-dependent. In a serious anaerobic infection, the enhanced killing is the primary benefit. In chronic inflammatory disease, the anti-inflammatory effect is more relevant.

Stem Cell Mobilization

HBOT mobilizes stem cells from the bone marrow into the circulation. In a controlled human study, Thom and colleagues found that circulating CD34+ stem cells doubled after a single 2-hour exposure at 2.0 ATA and rose roughly eightfold over a course of 20 treatments, an effect the authors traced to nitric oxide signaling.4 These cells participate in tissue repair and vascular regeneration. The clinical significance is clearest in wound healing, where mobilized stem cells contribute directly to closure; the broader implications for immune function remain an area of research.

~8xIncrease in circulating CD34+ stem cells over 20 HBOT sessions (roughly doubled after a single session)Thom et al., 2006, Am J Physiol Heart Circ Physiol

Can HBOT Help If You Get Sick Often?

There is no clinical trial evidence that HBOT reduces the frequency of common infections in otherwise healthy people. Many wellness centers market sessions as immune support for preventing illness or recovering faster from minor infections. The honest assessment is that the immune effects documented in research show up in specific challenges (established infection, chronic inflammation, hypoxic compromised tissue) rather than as preventive maintenance for a well-functioning immune system.

0Clinical trials showing HBOT prevents everyday infections or “boosts” immunity in healthy peopleNo trial evidence identified; UHMS/FDA indications are disease-specific

For general immune health, well-evidenced lifestyle strategies (adequate sleep, regular physical activity, a nutrient-dense diet, stress management) have more documented benefit than HBOT in healthy populations. The alternatives to HBOT article addresses this context, and the U.S. Food and Drug Administration has warned consumers against unproven HBOT marketing claims.5

Does HBOT Help Autoimmune Conditions?

The immune-enhancing side of HBOT raises a fair question: could it worsen autoimmune conditions where the immune system is already overactive? Current evidence does not strongly support that concern at typical therapeutic doses, and the anti-inflammatory NF-kB effect described above points the other way. Still, it is a legitimate consideration for people with active autoimmune disease, and it should be discussed with a physician. The autoimmune conditions and HBOT article covers this nuance, and the relationship with cancer immunity is handled separately in the cancer and HBOT guide.

The Oxygen Paradox in Immune Function

HBOT’s relationship with oxidative stress is one of the more nuanced aspects of its immune effects. Oxygen at very high concentrations can generate reactive oxygen species that damage cells, the mechanism of oxygen toxicity at extreme exposures. But at therapeutic doses, HBOT appears to upregulate the body’s endogenous antioxidant defenses (superoxide dismutase, catalase, glutathione peroxidase), producing a net reduction in oxidative stress rather than an increase.2 This hormetic response, where a mild stressor triggers an adaptive protective response, is one reason HBOT’s effects are dose-dependent. For immune function, it means HBOT enhances targeted oxidative killing in cells fighting infection while reducing the oxidative tissue damage of chronic inflammation.

Supporting Immune Recovery After Illness

After serious illness, surgery, or prolonged hospitalization, the immune system may be depleted and slow to recover. HBOT’s documented effects on stem cell mobilization and restoration of immune cell function in previously hypoxic tissue create theoretical grounds for use in post-illness recovery. This is clearest in post-COVID syndrome, where HBOT has positive trial evidence, and the concept may extend to recovery from other prolonged inflammatory states. The recovery and HBOT article provides additional context.

Nutritional Cofactors During HBOT

HBOT’s immune-supporting effects work best when the nutritional cofactors for immune function are in place. Zinc is essential for immune cell maturation and is commonly depleted in chronic illness. Vitamin D deficiency, common in northern latitudes, impairs both innate and adaptive immunity. Vitamin C supports neutrophil function, and selenium supports glutathione peroxidase, the antioxidant enzyme relevant to managing HBOT-induced oxidative stress. Patients pursuing HBOT for immune support should consider baseline labs (zinc, vitamin D, complete metabolic panel) and address deficiencies alongside treatment. The session guide and cost guide cover practical planning.

Frequently Asked Questions

Will HBOT help me get sick less often?

There is no clinical trial evidence showing that HBOT reduces the frequency of common infections in healthy people. The immune-enhancing effects documented in research appear in specific contexts of established infection or immune compromise, not general infection prevention in healthy populations. The Undersea and Hyperbaric Medical Society lists disease-specific indications such as gas gangrene and osteomyelitis, not preventive immune support.1

Can HBOT help if I’m immunocompromised?

It depends entirely on the cause. For local immune deficiency due to chronically hypoperfused tissue, as in diabetic foot infections, HBOT can meaningfully restore local immune function by raising oxygen tension where neutrophils need it.4 For systemic immunocompromise from HIV, chemotherapy, or immunosuppressant medications, the situation is different and requires careful physician evaluation before HBOT.

Does HBOT interact with immune-modulating medications?

Some medications used in autoimmune and inflammatory conditions require review before HBOT. Bleomycin and doxorubicin (chemotherapy agents) have known interactions with HBOT and are contraindications. High-dose steroids affect the oxygen toxicity risk profile. A full medication review by a hyperbaric physician is standard before starting treatment. The side effects and contraindications guide covers medication interactions.

Sources

  1. Undersea and Hyperbaric Medical Society. Indications for Hyperbaric Oxygen Therapy (14th Edition). uhms.org
  2. Fang J, et al. Clinical efficacy and mechanisms of hyperbaric oxygen therapy in rheumatic and immune diseases. Frontiers in Medicine. 2025. DOI: 10.3389/fmed.2025.1706637
  3. Mei S, et al. Hyperbaric oxygen therapy modulates immune effector responses and reshapes peripheral immune tolerance: a narrative review. Frontiers in Immunology. 2026. PMCID: PMC12992055
  4. Thom SR, Bhopale VM, Velazquez OC, Goldstein LJ, Thom LH, Buerk DG. Stem cell mobilization by hyperbaric oxygen. Am J Physiol Heart Circ Physiol. 2006;290(4):H1378-H1386. DOI: 10.1152/ajpheart.00888.2005
  5. U.S. Food and Drug Administration. Hyperbaric Oxygen Therapy: Don’t Be Misled. 2021. fda.gov

Medical Disclaimer

The content on BaricBoost.com is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Seph Fontane Pennock

Seph Fontane Pennock

Author

Seph Fontane Pennock is the founder of BaricBoost.com and Regenerated.com, a clinic directory for regenerative medicine serving 10,000+ providers across the United States. He previously built and sold PositivePsychology.com, which grew to 19 million users and became the largest evidence-based positive psychology resource on the web. Seph brings direct experience as an HBOT patient, having completed protocols at clinics across three continents while navigating mold illness, systemic inflammation, and autoimmune conditions. His treatment journey includes hyperbaric oxygen therapy, peptide protocols, NAD+ therapy, and consultations with specialists from Dubai to Cape Town to Mexico. This combination of entrepreneurial track record and lived patient experience shapes everything published on BaricBoost.com. Every article is grounded in peer-reviewed research, informed by real clinical encounters, and written for patients making high-stakes treatment decisions. Seph's focus is on bringing transparency, scientific rigor, and practical guidance to the hyperbaric oxygen therapy space.

Website

Previous Article

Hyperbaric Chamber for Memory Loss: Can HBOT Restore Cognitive Function?

Next Article

Hyperbaric Chamber for Radiation Injury: Treating Late Effects of Radiotherapy

One Email a Week.
Better Health Decisions.

Weekly breakdowns of the latest HBOT, ozone therapy, and oxygen therapy research. Clinical insights, treatment protocols, and evidence-based guidance for patients and practitioners.
Trusted by patients, clinicians, and researchers worldwide